Page last updated: 2024-08-22

gadolinium and sorafenib

gadolinium has been researched along with sorafenib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flaherty, KT; Heitjan, DF; Kang, HC; Keefe, SM; O'Dwyer, PJ; Rosen, MA; Siegelman, ES; Tan, KS	1
Chen, X; Liu, C; Lu, Y; Miao, H; Tang, B; Wang, L; Xu, Q; Yang, Z	1
Jiang, D; Liu, Y; Wang, T; Xiao, Y; Yang, S; Yu, D; Zhang, B; Zhang, J; Zhang, N	1

Trials

1 trial(s) available for gadolinium and sorafenib

Article	Year
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. AJR. American journal of roentgenology, 2013, Volume: 200, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Female; Gadolinium; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib	2013

Article

Year

MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib.

AJR. American journal of roentgenology, 2013, Volume: 200, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Female; Gadolinium; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib

2013

Other Studies

2 other study(ies) available for gadolinium and sorafenib

Article	Year
Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats. BMC gastroenterology, 2015, Nov-16, Volume: 15 Topics: Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cytokines; Dimethylnitrosamine; Drug Therapy, Combination; Gadolinium; Hepatic Stellate Cells; Hepatocytes; Hydroxyproline; Kupffer Cells; Liver; Liver Cirrhosis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sorafenib	2015
Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment. Colloids and surfaces. B, Biointerfaces, 2016, May-01, Volume: 141 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Contrast Media; Drug Delivery Systems; Drug Liberation; Female; Gadolinium; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Niacinamide; Phenylurea Compounds; Sorafenib; Tissue Distribution; Treatment Outcome; Tumor Burden	2016

Article

Year

Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.

BMC gastroenterology, 2015, Nov-16, Volume: 15

Topics: Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cytokines; Dimethylnitrosamine; Drug Therapy, Combination; Gadolinium; Hepatic Stellate Cells; Hepatocytes; Hydroxyproline; Kupffer Cells; Liver; Liver Cirrhosis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sorafenib

2015

Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.

Colloids and surfaces. B, Biointerfaces, 2016, May-01, Volume: 141

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Contrast Media; Drug Delivery Systems; Drug Liberation; Female; Gadolinium; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Niacinamide; Phenylurea Compounds; Sorafenib; Tissue Distribution; Treatment Outcome; Tumor Burden

2016